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ABSTRACT
Objectives To determine whether erosive osteoarthritis
shares the same pattern of joint involvement and risk
profile as increasing grades of non-erosive hand
osteoarthritis.
Methods Participants were from two population-based
cohorts, aged ≥50 years, reporting hand symptoms in the
previous month. Interphalangeal joints were assessed for
erosive osteoarthritis (Verbruggen–Veys erosive or
remodelled phase) and radiographic osteoarthritis (sliding
cut-offs of K&L≥2, K&L≥3 and K&L=4). At the joint level,
similarities in the frequency and pattern of erosive and non-
erosive osteoarthritis were assessed by Spearman’s rank
correlation coefficients and generalised estimating
equations. At the person level, individuals with erosive
osteoarthritis were compared to those with non-erosive
osteoarthritis using logistic regression, adjusted for age and
gender (aOR), for the following exposures: family history,
previous injury, overuse and metabolic factors (BMI,
dyslipidaemia, hypertension, diabetes).
Results In 1076 symptomatic participants the ranked
frequency of involvement for erosive joints was comparable
to joints with K&L≥3 and K&L=4 (r>0.95). Patterns of
joint involvement in erosive osteoarthritis were strongest for
symmetry (aOR=6.5; 95% CI 3.0 to 14.1), followed by row
(2.0; 0.8 to 5.0) and ray (0.3; 0.0 to 2.5), which was
similar to joints with K&L≥3 and K&L=4. Individuals with
erosive osteoarthritis (n=80) had an increased risk of
metabolic syndrome (2.7; 1.0 to 7.1), notably
dyslipidaemia (4.7; 2.1 to 10.6) compared with non-
erosive osteoarthritis classed K&L≥3 (n=193).
Conclusions The similar frequency of radiographic joint
involvement and patterning in erosive osteoarthritis and
more severe non-erosive osteoarthritis is consistent with
prevalent erosive osteoarthritis being a severe form of hand
osteoarthritis rather than a distinct entity. Metabolic
exposures, dyslipidaemia in particular, may be implicated in
erosive osteoarthritis.
INTRODUCTION
Inflammatory osteoarthritis was first described by
Crain1 in 1961 and the term erosive osteoarthritis
was coined 5 years later by Peter et al.2 Erosive
osteoarthritis predominantly affects the interpha-
langeal joints (IPJ) and is characterised by abrupt
onset with inflammation. Those affected experience
tissue swelling, stiffness, erythema, and report con-
siderable pain and functional limitation.2–4 Hand
radiographs demonstrate a characteristic central
erosion with collapse of the subchondral bone and
a ‘gull-wing’ or ‘saw-tooth’ deformity.4 5 Complete
loss or pseudo-widening of the joint space may be
apparent.6 Over time, subsequent reparative altera-
tions are frequently seen with a new, but irregular
subchondral plate and a new joint space.6 In this
remodelling phase osteolytic areas gradually recede
and large osteophytes develop.7
The prevalence of erosive osteoarthritis in the
general population has been estimated at 2.8% rising
to 10.2% in those with symptomatic osteoarthritis.8
Erosive osteoarthritis has been found to have poorer
clinical and radiographic outcomes than non-erosive
hand osteoarthritis.9–12 European League Against
Rheumatism (EULAR) recommendations for the diag-
nosis of hand osteoarthritis have suggested that erosive
osteoarthritis should be considered as a subset of hand
osteoarthritis.13 However, the etiopathogenesis is not
clear and poorer clinical outcomes may be the result
of erosive osteoarthritis being a discrete disease entity
rather than a more severe form of hand osteoarthritis.
Studies and case reports have suggested that
erosive osteoarthritis affects distal interphalangeal
(DIP) joints more frequently than the proximal inter-
phalangeal (PIP) joints and that it is highly symmet-
rical.3 14 15 These are the same patterns of
involvement that are reported in non-erosive hand
osteoarthritis.16 17 Risk factors that are known for
hand osteoarthritis include female gender, older age,
family history, obesity, previous hand injury and
occupational and recreational activities.13 Some of
these risk factors, including a female predominance,
obesity and a hereditary aspect, have also been
reported for erosive osteoarthritis.18 To date, no
studies have directly compared joint involvement and
risk factors in erosive osteoarthritis to increasing
grades of non-erosive osteoarthritis.
This study aims to investigate whether erosive
osteoarthritis is a discrete disease entity or at the
severe end of the hand osteoarthritis continuum.
We examined similarities in the frequency and pat-
terns of joint involvement between erosive osteo-
arthritis and increasing grades of non-erosive
radiographic hand osteoarthritis, and compared
risk factor profiles between individuals with erosive
osteoarthritis and non-erosive radiographic hand
osteoarthritis.
METHODS
Study population
Participants were recruited from a prospective
observational cohort study undertaken in North
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Staffordshire: the Clinical Assessment Study of the Hand
(CASHA). All adults aged 50 years and older registered with
two general practices were invited to participate at baseline in a
two-stage self-report questionnaire.19 In the UK over 95% of
people are registered with general practices, thus providing con-
venient general population sampling frames.20 Those with hand
pain or hand problems in the past 12 months were invited to
research clinics that included an interview, clinical assessment
and radiographs.
Participants reported the frequency of hand pain, aching or
stiffness in the past month (no days, few days, some days, most
days or all days). Those who reported symptoms on a few days
or more were deemed symptomatic and eligible for inclusion in
the analyses. Participants were excluded if general practice or
local rheumatology hospital medical records or a consultant
musculoskeletal radiologist identified them as having inflamma-
tory arthritis (rheumatoid arthritis, psoriatic arthritis). Those
with no hand radiographs or missing radiographic data were
also excluded.
The sample was enriched from an identically performed
survey in a similar population to increase the number of indivi-
duals with erosive osteoarthritis included in the analysis. In the
Clinical Assessment Study of the Knee (CASK) all adults aged
50 years and older registered with three general practices in
North Staffordshire were invited to participate at baseline in the
same two-stage self-report questionnaire.21 Individuals reporting
knee pain were invited to attend research clinics and received an
identical hand assessment and hand radiographs to those in the
CASHA study. All individuals included in the analysis had hand
pain on a few days or more in the previous month.
The North Staffordshire Local Research Ethics Committee
approved both these studies (LREC project no. 1430). All parti-
cipants provided written informed consent.
Data collection
Radiographic assessment and scoring
Posterior–anterior radiographs of the hands were taken with separ-
ate exposures for each hand according to a standardised proto-
col.19 21 The Kellgren and Lawrence (K&L) grading system was
used by two trained readers (CASHA: MM; CASK: JH) to grade
osteoarthritis in 16 joints in each hand.22 Intrarater reliability for
the presence of osteoarthritis (K&L≥2) in an individual joint was
excellent (unweighted mean kappa=0.92 and 0.85, mean percent-
age agreement=98% and 98% for reader 1 and 2, respectively)
and interrater reliability was moderate (unweighted mean
kappa=0.5, mean percentage agreement=90%). The presence of
erosive osteoarthritis in the IPJ (rays 2–5) was determined using the
Verbruggen–Veys anatomical phase progression score by a single
reader (WYK), intrarater reliability was excellent (unweighted
mean kappa=0.94, mean percentage agreement= 98%).6 Knee
radiographs were also taken and scored for the presence of
osteoarthritis.19 21
Risk factors
Demographic and socioeconomic data including gender, age,
occupation and education were collected in the baseline survey
along with self-reported previous hand injury and excessive use
of hands in either employment or pastimes. At the research
clinics, participants were asked whether their parents or siblings
had arthritis, and height and weight were measured to calculate
the body mass index (BMI).
A review of general practice medical records was undertaken
for a 2-year period before clinic attendance for participants
providing permission (n=1007, 94%). General practice
consultations in the UK are coded for medical diseases, symp-
toms and procedures (read codes) using a hierarchical method.
The five participating practices were fully computerised and the
completeness of their coding of consultations has been subject
to regular quality reviews.23 24 Participants with a diagnosis and
consultations for hypertension, type 2 diabetes or impaired
fasting glucose and dyslipidaemia or prescription of a
lipid-regulating drug were identified. Metabolic syndrome was
defined as the presence of three or more of the following:
BMI>30 kg/m2, hypertension, dyslipidaemia and type 2 dia-
betes or impaired fasting glucose.
Case definitions
All individuals included in this analysis were symptomatic (pain,
aching or stiffness on a few days or more in the past month).
Analysis was completed on two levels: joint and person.
Erosive osteoarthritis in a joint was defined as having eroded
‘E’ or remodelled ‘R’ phase of the Verbruggen–Veys anatomical
phase progression score. Non-erosive radiographic hand osteo-
arthritis in a joint was defined by sliding cut-offs of K&L
grades: K&L≥2, K&L≥3 and K&L=4.
At the person level, individuals with erosive osteoarthritis
were defined as having one or more IPJ with eroded ‘E’ or
remodelled ‘R’ phase of the Verbruggen–Veys anatomical phase
progression score. Reference groups consisted of individuals free
of erosive osteoarthritis who had increasing grades of radio-
graphic osteoarthritis: K&L≥2, K&L≥3 and K&L=4 defined
by the highest grade present in the IPJ.
Statistical analysis
The frequency of joint involvement was examined for erosive
osteoarthritis and increasing grades of non-erosive radiographic
osteoarthritis by ranking the IPJ in the order that they were
most frequency affected, and Spearman rank correlation coeffi-
cients were used to compare the rank order. Analysis of the pat-
terns of joint involvement by symmetry (same joint opposite
hand), row (same row same hand) and ray (same ray same hand)
were undertaken using three separate generalised estimating
equation models to account for the lack of independence in the
data for multiple hand joints in a single individual. Using sym-
metry as an example, the aim of the model was to test whether
having osteoarthritis in a single joint increased the odds of
having osteoarthritis in the same joint on the opposite hand. All
generalised estimating equation models were fitted using an
exchangeable correlation structure and robust SE. Model results
are presented as OR adjusted for potential confounding by age,
gender, hand joint, hand side and the number of affected IPJ.
Analysis was undertaken at the person level to compare the
descriptive characteristics and risk factors of individuals with
erosive osteoarthritis to reference groups with increasing grades
of non-erosive radiographic osteoarthritis. The OR for a risk
factor in those with erosive osteoarthritis compared to reference
groups were calculated, and adjusted for age and gender.
Analyses were performed using IBM SPSS Statistics V.20 and
STATA V.11.0. All tests were two tailed and a p value of less
than 0.05 was considered statistically significant.
RESULTS
Study population
In total, 15 396 adults aged 50 years and over from five general
practices in North Staffordshire were mailed a two-stage survey
from which CASHA and CASK study participants were
recruited (see supplementary figure 1, available online only, for
full details of the recruitment process). In total, 1167
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participants reporting hand pain on a few days or more in the
previous month attended the research clinics (CASHA n=578;
CASK n=589). Even though only a small proportion of those
surveyed attended research clinics the CASK sample has been
shown to be representative of the symptomatic general popula-
tion and similar analyses in CASHA resulted in the same
conclusions.25
Following exclusions for inflammatory arthritis (n=44), no hand
X-rays (n=6) and missing X-ray data (n=41), 1076 participants
were included in the analysis (CASHA n=521; CASK n=555),
60% women, mean age 64.8 years (SD 8.3, range 50–93).
Frequency of joint involvement##
In total, 8608 hand joints were examined, with K&L≥2 present
in 1754 joints, K&L≥3 in 425 joints, K&L=4 in 112 joints and
erosive osteoarthritis in 207 joints.
Erosive osteoarthritis had the same rank involvement for the
DIP joints as moderate–severe (K&L≥3) and severe (K&L=4)
osteoarthritis in the right hand and severe osteoarthritis
(K&L=4) in the left hand (table 1). In both hands statistically
significant associations were seen for the rank order of joints
with erosive osteoarthritis and moderate–severe osteoarthritis
(K&L≥3), and for erosive osteoarthritis and severe osteoarthritis
(K&L=4) (table 1, Spearman r≥0.95). Fewer similarities were
seen when the frequency of erosive joint involvement was com-
pared to the presence of any radiographic osteoarthritis
(K&L≥2) (table 1).
Patterns of joint involvement
Trends in the patterning of joint involvement were strongest by
symmetry followed by row and then ray for erosive osteoarth-
ritis and increasing grades of radiographic osteoarthritis,
although in erosive joints statistically significant odds were only
seen for symmetrical patterning (table 2). The strength of associ-
ation for symmetry and ray was similar for erosive osteoarthritis
compared with moderate–severe (K&L≥3) and severe hand
osteoarthritis (K&L=4) (table 2).
Demographic and radiographic characteristics
In total, 80 participants were classed as having erosive osteo-
arthritis (mean number of erosive joints=2.6 (SD= 1.9),
range=1–9). As similarities were seen between erosive osteo-
arthritis and moderate–severe and severe osteoarthritis in the
joint patterning, analyses focused on the reference groups of
193 individuals with K&L≥3 and the 68 who had K&L=4. In
individuals with erosive osteoarthritis the distribution of gender
and age was comparable to those with moderate–severe
(K&L≥3) and severe (K&L=4) osteoarthritis (table 3).
Individuals with erosive osteoarthritis had thumb metacarpo-
phalangeal and first carpometacarpal joint osteoarthritis slightly
more often while symptomatic radiographic knee osteoarthritis
was less frequent compared to those with more severe
non-erosive osteoarthritis (table 3); however, the 95% CI
showed none of these differences to be statistically significant
(data not shown).
Risk factors
After adjustment for potential confounders, individuals with
erosive osteoarthritis had increased odds of having dyslipidae-
mia (aOR=4.7) and a classification of metabolic syndrome
(aOR= 2.7) when compared to individuals with non-erosive
radiographic osteoarthritis K&L≥3 (table 4). The same patterns
were seen when erosive osteoarthritis was compared to the ref-
erence group with K&L=4.
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DISCUSSION
Our analysis has identified an association between selected meta-
bolic factors, notably dyslipidaemia, and the risk of erosive hand
osteoarthritis in a population sample of symptomatic indivi-
duals. Reference groups were individuals with moderate–severe
and severe non-erosive hand osteoarthritis and were selected
from the same underlying population. This is important given
the similar pattern of joint involvement and clustering by sym-
metry, row and ray among individuals with erosive osteoarthritis
and those with increasing grades of non-erosive hand osteoarth-
ritis. Our findings, if confirmed in other longitudinal studies,
may suggest a role for systemic metabolic factors in the evolu-
tion from severe hand osteoarthritis to erosive osteoarthritis.
This research directly compared the frequency and patterning
of joint involvement in erosive osteoarthritis to joints with
increasing grades of radiographic osteoarthritis and found
strong similarities between erosive osteoarthritis and moderate–
severe and severe non-erosive osteoarthritis. Our study confirms
that erosive osteoarthritis, like more severe hand osteoarthritis,
targets the DIP joints more frequently than the PIP joints, and
clustering of joint involvement was strongest for symmetry, fol-
lowed by row and then ray.3 12 14 16 26 The same similarity of
patterning was less evident for less severe grades of osteoarth-
ritis that required only the presence of a definite osteophyte.
This might imply that erosive osteoarthritis is less strongly
related to osteophytosis than joint space narrowing, which is in
keeping with research by Bijsterbosch et al,27 who found that
erosive evolution in a joint was associated with the presence of
joint space narrowing at baseline but not osteophytes. Together,
these observations support the consecutive anatomical phases of
the Verbruggen–Veys’s scoring system.6
We examined a number of metabolic risk factors that have
been associated with osteoarthritis and hand osteoarthritis.28–31
We found that compared with moderate–severe and severe
non-erosive hand osteoarthritis, individuals with erosive osteo-
arthritis were more likely to have a diagnosis and consultation
for dyslipidaemia and be classed with metabolic syndrome.
Erosive evolution has been found to cluster strongly within
Table 3 Demographic and radiographic characteristics of individuals with erosive osteoarthritis compared to the reference groups with
increasing grades of non-erosive radiographic hand osteoarthritis
K&L≥3 K&L=4 Erosive osteoarthritis
Number n=193 n=68 n=80
Age range, years 52–91 55–85 51–87
Mean age, years (SD) 68.9 (8.1) 69.1 (7.5) 69.2 (7.8)
Female gender 79.3% 79.4% 83.8%
Thumb IPJ osteoarthritis* 63.7% 69.1% 68.8%
Thumb MCP osteoarthritis* 14.0% 16.2% 23.8%
First CMC osteoarthritis* 71.0% 66.2% 76.3%
Trapezioscaphoid joint osteoarthritis* 30.6% 27.9% 29.1%
MCP osteoarthritis† 30.6% 35.3% 32.5%
Symptomatic radiographic knee osteoarthritis‡ 68.5% 59.7% 55.4%
Manual occupation 56.3% 56.5% 48.6%
Attended higher education 14.9% 16.7% 21.5%
Family history of arthritis 68.4% 63.2% 71.2%
Previous hand injury 25.4% 24.6% 32.9%
Excessive hand use at work or in pastimes 77.6% 76.2% 83.8%
BMI>30 kg/m2 34.4% 35.3% 37.5%
Type 2 diabetes or impaired fasting glucose 9.3% 10.3% 6.2%
Hypertension 37.8% 29.4% 43.8%
Dyslipidaemia 6.2% 8.8% 21.2%
Prescribed a lipid-regulating drug 17.1% 16.2% 20.0%
Metabolic syndrome§ 4.1% 2.9% 11.2%
BMI, body mass index; CMC, carpometacarpal joint; IPJ, interphalangeal joint; K&L, Kellgren and Lawrence; MCP, metacarpophalangeal joint.
*Radiographic osteoarthritis determined by presence of K&L≥2.
†Radiographic osteoarthritis determined by the presence of K&L≥2 in one or more joints in the joint group.
‡Symptomatic radiographic knee osteoarthritis of tibiofemoral or patella-femoral joints of either knee (K&L≥2 on posterior–anterior or skyline views or posterior or lateral osteophytes
Burnett grade≥1 on the lateral views).
§Metabolic syndrome was defined as the presence of three or more of the following: BMI>30 kg/m2, hypertension, dyslipidaemia and type 2 diabetes or impaired fasting glucose.
Table 2 Patterns of joint involvement by symmetry, row and ray for increasing grades of radiographic osteoarthritis and erosive osteoarthritis
Groups of Joints
K&L≥2 K&L≥3 K&L=4 Erosive osteoarthritis
aOR (95% CI) aOR (95% CI) aOR (95% CI) aOR (95% CI)
Same joint, opposite hand 3.8 (3.1 to 4.5) 6.0 (4.2 to 8.5) 6.0 (3.4 to 10.5) 6.5 (3.0 to 14.1)
Same row, same hand 3.2 (2.7 to 3.8) 3.1 (2.1 to 4.6) 4.2 (2.3 to 7.8) 2.0 (0.8 to 5.0)
Same ray, same hand 0.9 (0.7 to 1.2) 0.5 (0.3 to 0.9) 0.3 (0.1 to 0.8) 0.3 (0.03 to 2.5)
aOR, adjusted OR for age, gender, hand joint, hand side and number of affected interphalangeal joints; K&L, Kellgren and Lawrence.
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individuals, which suggests that the evolution of hand osteoarth-
ritis to erosive osteoarthritis has a large systemic component.27
A previous study found BMI to be increased in individuals with
erosive osteoarthritis compared to non-erosive osteoarthritis.8
This was not replicated in the present findings; however, the
current analysis was designed to compare risk factors for erosive
osteoarthritis to more severe hand osteoarthritis to determine
whether they have the same risk factor profile. Therefore, BMI
might be a risk factor for more severe hand osteoarthritis, but it
does not discriminate between those with severe hand osteoarth-
ritis and erosive osteoarthritis. Another study found significantly
increased odds of hypercholesterolaemia in patients with erosive
and non-erosive osteoarthritis compared to controls, but no
assessment was made between erosive osteoarthritis and more
severe non-erosive hand osteoarthritis.32 Increased serum chol-
esterol has been shown to be a risk factor for generalised osteo-
arthritis,33–35 and the use of statins has been found to lead to a
reduction in both the incidence and progression of osteoarth-
ritis,36 37 supporting the lack of association seen in the current
analyses with lipid-regulating drugs. The exact mechanism is not
yet known but osteoarthritis is believed to share similar bio-
chemical and inflammatory pathways to metabolic disorders,38 39
and dyslipidaemia may alter lipid metabolism in a number of
joint tissues.40–42 The association between osteoarthritis and a
number of metabolic risk factors has been noted in a number of
studies.29 30 43 A population-based study recently demonstrated
a significant dose–response relationship between the presence,
incidence and progression of knee osteoarthritis and increasing
numbers of metabolic factors.31 44 Therefore, as we found in
this analysis, more severe forms of osteoarthritis, which include
erosive osteoarthritis, may be associated with the presence of
multiple metabolic factors.
Erosive osteoarthritis has been considered a separate disease
entity as unlike non-erosive hand osteoarthritis it typically has
an abrupt onset.2 3 Synovial pathology has shown an intense
hypertrophy with acute inflammatory changes consistent with
inflammatory arthritis.14 In one study, 15% of erosive osteoarth-
ritis patients later developed seropositive rheumatoid arthritis.45
However, once the inflammatory phase has diminished histo-
logical samples are comparable to non-erosive hand osteoarth-
ritis, suggesting inflammation is only a transitory phase.46
A further indication that erosive osteoarthritis may be a more
severe form of hand osteoarthritis is that erosive osteoarthritis is
seen in association with the same radiographic features of osteo-
arthritis and never in the absence of osteoarthritic changes.2–4
Research, including the present findings, has found that erosive
osteoarthritis frequently affects the same hand joints as more
severe non-erosive hand osteoarthritis.14 Nodes often occur in
individuals with erosive osteoarthritis,47 and the greater clinical
burden in erosive osteoarthritis compared to non-erosive osteo-
arthritis is thought to be largely due to the increased presence
of nodes.11 Levels of serum hyaluronic acid, an important com-
ponent of articular cartilage and synovial fluid, are increased in
individuals with erosive compared to non-erosive osteoarthritis,
signifying greater disease activity.10 However, the potential
erosive-specific risk factors of dyslipidaemia and metabolic syn-
drome found in the current research may indicate why some go
on to develop a more severe form of hand osteoarthritis.
A few methodological limitations should be considered when
interpreting the findings of this study. Although all individuals
included in the current analysis had recent hand symptoms,
those from CASK were recruited on the basis on having knee
pain and could have a more widespread form of osteoarthritis;
however, no excess in the frequency of erosive or non-erosive
hand osteoarthritis was seen in the CASK participants. This
study was limited by its small sample size as erosive osteoarth-
ritis is a relatively rare condition; nevertheless, other
population-based studies, such as Framingham and Rotterdam,
had comparable numbers with erosive osteoarthritis.8 15 The
focus of this research was specifically on the radiographic pres-
entation of erosive osteoarthritis in relation to increasing grades
of non-erosive hand osteoarthritis and not the clinical or symp-
tomatic aspects of the condition. General practice medical
records were used to determine the metabolic exposures, except
for BMI. However, all doctors making a diagnosis of a meta-
bolic condition would be working to UK clinical guidelines.
Furthermore, we considered whether individuals with erosive
osteoarthritis might be more likely visit their general practi-
tioner thereby increasing the possibility of the diagnosis of a
metabolic risk factor. Sensitivity analysis found this was not the
case. Finally, in this analysis individuals with prevalent erosive
osteoarthritis were used along with a limited retrospective
period for the ascertainment of metabolic exposures. A longer
period of retrospective review and the use of incident erosive
osteoarthritis would allow a more thorough analysis to be
completed.
In conclusion, the frequency and patterning of joint involve-
ment in erosive osteoarthritis is similar to that seen in moder-
ate–severe and severe non-erosive radiographic osteoarthritis,
which is consistent with erosive osteoarthritis being a more
severe form of hand osteoarthritis rather than a distinct entity.
Metabolic exposure, and dyslipidaemia in particular, may be
associated with erosive osteoarthritis.
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